1 asset in Tuberous Sclerosis 2
Therapeutic assets addressing Tuberous Sclerosis 2, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Nab-Sirolimus Tuberous Sclerosis 2 | Aadi Bioscience, Inc. | P2 | CCC (53) |
Therapeutic assets addressing Tuberous Sclerosis 2, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Nab-Sirolimus Tuberous Sclerosis 2 | Aadi Bioscience, Inc. | P2 | CCC (53) |